z-logo
open-access-imgOpen Access
Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation
Author(s) -
Neill J. Liptrott,
Paul Curley,
Darren Moss,
David Back,
Saye Khoo,
Andrew Owen
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt225
Subject(s) - nevirapine , intracellular , tenofovir , pharmacokinetics , virus , monocyte , virology , reverse transcriptase inhibitor , biology , pharmacology , chemistry , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy , immunology , viral load , sida , genetics
There is no pharmacokinetic interaction between tenofovir and nevirapine, but a higher emergence rate of resistance mutations has been reported when these drugs are coadministered. We sought to examine if there is a potential intracellular interaction that may account for the emergence of resistant virus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom